Defective Products & Drug Recalls in VA Archives - Page 6 of 68 - Shapiro, Washburn & Sharp

Drugmakers Paying Billions for Overpromoting Psychiatric Medications With Serious Side Effects

AstraZeneca last week announced that it would pay a total of $520 million to settle federal and whistleblower charges that it had improperly marketed its medication Seroquel. The size of these combined settlements, first reported in the New York Times, may seem large. Compared with the $1.4 billion Eli Lilly agreed to pay in fines…

read more